Dual vs triple antithrombotic therapy in atrial fibrillation and acute coronary syndrome: An updated meta-analysis of randomized controlled trials

MLA

Sainbayar, Enkhtsogt, et al. “Dual vs Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials.” Journal of Investigative Medicine, no. Preprints, Jan. 2024. EBSCOhost, https://doi.org/10.1177/10815589241270640.

APA

Sainbayar, E., Pham, H. N., Olson, A., Ibrahim, R., Grewal, H., Salih, M., Mamas, M. A., & Lee, K. (2024). Dual vs triple antithrombotic therapy in atrial fibrillation and acute coronary syndrome: An updated meta-analysis of randomized controlled trials. Journal of Investigative Medicine, Preprints. https://doi.org/10.1177/10815589241270640

Chicago

Sainbayar, Enkhtsogt, Hoang Nhat Pham, April Olson, Ramzi Ibrahim, Harneet Grewal, Mohammed Salih, Mamas A Mamas, and Kwan Lee. 2024. “Dual vs Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials.” Journal of Investigative Medicine, no. Preprints (January). doi:10.1177/10815589241270640.